ALSP Orchid Acquisition Corporation I
ALORU
NASDAQ Global Market10.84
USD
-0.58
- -
CIK
0001883962
CUSIP
G0231L115
Return %
Stock
S&P500
1Y
6.27
18.21
3Y
7.43
63.29
5Y
7.43
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Thong Q. Le
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 2815 Eastlake Avenue East Seattle WA United States of America 98102
- IPO Date
- Nov 19, 2021
- CIK
- 0001883962
- Similar Companies
- Business
- ALSP Orchid Acquisition Corporation I is a blank check company incorporated in the Cayman Islands in 2021 and headquartered in Seattle, Washington. The company has no significant operations and focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities; it targets life science companies in North America and Singapore, with an emphasis on those developing assets and next-generation platform technologies with broad applicability. Its securities include units consisting of one Class A ordinary share and one-half of one redeemable warrant exercisable at $11.50 per share, which were offered in an initial public offering of 17.25 million units priced at $10.00, raising $172.5 million in November 2021 and listed on Nasdaq under the ticker ALORU. In November 2023, the company announced the redemption of all outstanding Class A ordinary shares at approximately $10.86 per share and ceased operations after failing to complete an initial business combination within the required timeframe under its Amended and Restated Memorandum and Articles of Association; it filed Form 15 with the SEC on November 24, 2023, to terminate registration of its securities under Section 12(g) of the Securities Exchange Act of 1934 and suspend reporting obligations, with only one holder of record remaining.